Deutsche Bank Ag\ Aquestive Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

$287 Billion
Q3 2025

A detailed history of Deutsche Bank Ag\ transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 74,804 shares of AQST stock, worth $403,193. This represents 0.0% of its overall portfolio holdings.

Number of Shares

74,804

Previous 64,323 16.29%

Holding current value

$403,193

Previous $212,000 97.17%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$3.4 - $5.99 $35,635 - $62,781	10,481 Added 16.29%	74,804 $418,000
Q2 2025 Aug 12, 2025	BUY	$2.22 - $3.58 $21,585 - $34,808	9,723 Added 17.81%	64,323 $212,000
Q1 2025 May 09, 2025	SELL	$2.54 - $3.75 $18,768 - $27,708	-7,389 Reduced 11.92%	54,600 $158,000
Q4 2024 Jun 30, 2025	BUY	$3.46 - $5.64 $25,565 - $41,673	7,389 Added 13.53%	61,989 $219,000
Q4 2024 Feb 14, 2025	BUY	$3.46 - $5.64 $83,628 - $136,318	24,170 Added 63.91%	61,989 $219,000

Q3 2024 Jun 26, 2025	SELL	$2.4 - $5.09 $40,274 - $85,415	-16,781 Reduced 30.73%	37,819 $188,000
Q3 2024 Nov 13, 2024	BUY	$2.4 - $5.09 $90,765 - $192,498	37,819 New	37,819 $188,000
Q4 2021 Feb 11, 2022	SELL	$3.69 - $6.37 $77 - $133	-21 Closed	0 $0
Q3 2021 Nov 04, 2021	SELL	$3.25 - $4.66 $4,475 - $6,416	-1,377 Reduced 98.5%	21 $0
Q2 2021 Aug 11, 2021	SELL	$3.29 - $5.21 $41,894 - $66,344	-12,734 Reduced 90.11%	1,398 $6,000
Q1 2021 May 13, 2021	SELL	$4.17 - $6.73 $19,953 - $32,203	-4,785 Reduced 25.29%	14,132 $73,000
Q4 2020 Feb 16, 2021	SELL	$4.65 - $7.79 $424,824 - $711,694	-91,360 Reduced 82.85%	18,917 $101,000
Q3 2020 Nov 12, 2020	BUY	$4.12 - $9.09 $411,620 - $908,163	99,908 Added 963.53%	110,277 $535,000
Q2 2020 Aug 13, 2020	BUY	$1.84 - $6.44 $19,078 - $66,776	10,369 New	10,369 $50,000
Q3 2019 Nov 14, 2019	SELL	$3.04 - $4.91 $12,029 - $19,428	-3,957 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$3.72 - $6.95 $31,374 - $58,616	-8,434 Reduced 68.07%	3,957 $15,000
Q1 2019 May 15, 2019	BUY	$5.74 - $8.05 $45,426 - $63,707	7,914 Added 176.77%	12,391 $84,000
Q4 2018 Feb 14, 2019	SELL	$6.09 - $18.0 $44,913 - $132,750	-7,375 Reduced 62.23%	4,477 $27,000
Q3 2018 Dec 21, 2021	BUY	$15.0 - $18.96 $20,670 - $26,126	1,378 Added 13.16%	11,852 $207,000
Q3 2018 Nov 14, 2018	BUY	$15.0 - $18.96 $157,110 - $198,587	10,474 New	10,474 $182,000

Others Institutions Holding AQST

# of Institutions

164

Shares Held

65.9M

Call Options Held

794K

Put Options Held

457K

View Full List

About Aquestive Therapeutics, Inc.

Ticker AQST
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,350,700
Market Cap $288M
Description
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...

More about AQST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account